VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
43 hedge funds and large institutions have $29.1M invested in Viracta Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 39 reducing their positions, and 17 closing their positions.
Holders
43
Holders Change
-15
Holders Change %
-25.86%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
39
Closed
17
Calls
$1.41M
Puts
$681K
Net Calls
+$733K
Net Calls Change
+$634K
Top Buyers
1 |
BFM
1
Boothbay Fund Management
New York
|
$70K |
2 |
2
Wells Fargo
San Francisco,
California
|
$41K |